High Cost Sharing and Specialty Drug Initiation Under Medicare Part D: A Case Study in Patients With Newly Diagnosed Chronic Myeloid Leukemia
Loading...
Penn collection
Research Briefs
Degree type
Discipline
Subject
health insurance
medicare
Health Services Administration
Health Services Research
medicare
Health Services Administration
Health Services Research
Funder
Grant number
Copyright date
Distributor
Related resources
http://ldi.upenn.edu/brief/high-cost-sharing-and-specialty-drug-initiation-under-medicare-part-d-case-study-patients
http://www.ajmc.com/journals/supplement/2016/improving-patient-access-to-critical-therapies-in-the-age-of-cost-sharing/high-cost-sharing-and-specialty-drug-initiation-under-medicare-part-d-a-case-study-in-patients-with-newly-diagnosed-cml/P-1
http://www.ajmc.com/journals/supplement/2016/improving-patient-access-to-critical-therapies-in-the-age-of-cost-sharing/high-cost-sharing-and-specialty-drug-initiation-under-medicare-part-d-a-case-study-in-patients-with-newly-diagnosed-cml/P-1
Author
Huo, Hairong
Pettit, Amy R
Kumar, Rishab
Weiss, Brendan M
Huntington, Scott F
Contributor
Abstract
Medicare Part D beneficiaries with higher out-of-pocket costs are more likely to delay starting or not start a recommended specialty drug when newly diagnosed with leukemia. Policy changes are needed to ensure optimal access to specialty medications under Medicare Part D.
Advisor
Date Range for Data Collection (Start Date)
Date Range for Data Collection (End Date)
Digital Object Identifier
Series name and number
Publication date
2016-04-01